Recall Scope Identification
Scope identification determines affected lots, serials, and distribution, since an imprecise scope either misses devices or recalls far more than necessary.
Recall management software identifies affected devices and patients, coordinates notification, tracks replacement or correction, and documents effectiveness. Speed matters clinically: a Class I recall involves reasonable probability of serious harm, so identification delay has direct patient consequence rather than administrative cost.
Recall response is the moment every upstream traceability decision gets tested. Organizations that tracked devices carefully identify affected patients in hours; those that did not review charts for weeks. Taction Software builds medical device recalls management capability for both manufacturers executing field actions and hospitals receiving them.

Our experts are ready to understand your business goals.






























































Medical device recalls management software supports field actions from initiation through closure: identifying affected lots and serial numbers, determining which customers or patients received them, coordinating notification, tracking response and device return or correction, documenting effectiveness checks, and producing regulatory reporting. Hospitals need the receiving side, matching incoming recalls against their inventory and implant records. Our work sits within our broader medical devices and IoT practice.
Scope identification determines affected lots, serials, and distribution, since an imprecise scope either misses devices or recalls far more than necessary.
Recall database synchronization alerts hospitals to published recalls affecting devices they hold, replacing manual monitoring that misses notices.
Patient identification matches recalled devices against implant and usage records, which depends entirely on traceability capture quality.
Notification coordinates communication to facilities, clinicians, and where appropriate patients, with tracked delivery and acknowledgment.
Field correction tracking follows each affected unit through return, replacement, or in-place correction until the action is documented complete.
Effectiveness checks verify that notification reached recipients and action was completed, which regulators examine when reviewing recall closure.
Our medical device recalls management services cover scope determination, notification systems, patient matching, tracking workflow, and regulatory reporting. The capability that determines everything is upstream traceability: recall software cannot identify patients whose device records were never captured. We say so directly, since clients sometimes expect recall tooling to resolve traceability gaps it can only expose. Engagements typically open with an assessment of existing traceability data quality.
Scope analysis determines affected units from lot and distribution records, since precision here bounds both patient safety and unnecessary cost.
Database synchronization matches published recalls against holdings, alerting materials management rather than relying on manual notice review.
Patient matching uses implant and usage records, connecting through our HL7 integration services work to clinical systems.
Notification draws on our AI patient outreach capabilities where patient contact is appropriate, with clinical communication led by providers.
Response tracking follows acknowledgment and completion per recipient, producing the documentation effectiveness verification requires.
Reporting supports correction and removal obligations, with submission content approved by regulatory affairs rather than filed automatically.
The benefits concentrate in identification speed, notification completeness, and documented closure. Manual recall response consumes substantial staff time and produces uncertain completeness, particularly where affected patients must be identified from clinical records. We publish no figures on response time, notification rates, or recall effectiveness, because those depend entirely on traceability data quality and distribution complexity.
Automated matching against distribution and implant records identifies affected parties in hours where manual review takes weeks.
Tracked notification delivery with acknowledgment shows who was actually reached, rather than assuming a mailing list constituted notice.
Effectiveness records support recall closure with evidence, since regulators examine whether the action actually reached its intended scope.
Precise scope determination avoids recalling unaffected units, which is expensive and erodes trust in future notices from the same manufacturer.
Database synchronization alerts facilities to recalls affecting held inventory, addressing notices that arrive by mail and get missed.
Recall events connect with broader quality processes, complementing our incident reporting work on event documentation.
We deliver medical device recalls management projects in gated phases so quality, regulatory, and clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes traceability data quality first, since that determines what identification is achievable. Notification workflow is designed with the recognition that Class I recalls carry urgency: the system must support rapid execution rather than optimizing for administrative tidiness.
Discovery assesses traceability data quality honestly, since recall software can only identify affected parties whose device records exist.
Scope determination logic is designed with quality, since defining affected units too broadly or narrowly both carry serious consequences.
Notification is designed for urgency, since Class I actions involve reasonable probability of serious harm and delay has clinical consequence.
Integration reaches implant records where patient identification is required, which depends on device identifiers having been captured clinically.
Effectiveness tracking is built into execution rather than assembled afterward, since closure requires evidence that action reached its scope.
Rollout includes drill testing against historical recalls, with continuing support as distribution and regulatory requirements change.
Recall management operates under FDA correction and removal reporting requirements, recall classification determining urgency and scope, and quality system obligations covering field actions. Where patient identification is involved, records constitute PHI. Taction holds ISO 27001 certification. Two points deserve emphasis. Class I recalls involve reasonable probability of serious harm, so system design must support speed. And recall classification is an FDA and manufacturer determination rather than a software output.
Reporting obligations apply to corrections and removals, with submission content approved by regulatory affairs rather than generated and filed automatically.
Classification is determined by the manufacturer and FDA. Software supports execution and documentation rather than assessing hazard severity.
Class I actions involve probability of serious harm, so notification and identification workflow is designed for speed over administrative elegance.
Patient matching involves PHI. Our HIPAA compliance practice defines the controls applicable to that data.
Identification completeness is bounded by upstream capture. The system exposes traceability gaps rather than resolving them retroactively.
Deployments run in your cloud tenancy or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Taction Software was founded in 2013 and has spent over 12 years building healthcare and life sciences software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant honesty here is that recall software exposes traceability quality rather than fixing it. Clients sometimes expect recall tooling to solve identification problems created years earlier at the point of capture, and it cannot. Our leadership brings more than 20 years of personal experience in the field.
We state that identification completeness depends on upstream capture, since recall tooling exposes traceability gaps rather than resolving them.
We build for manufacturers and hospitals, understanding that execution and receipt are different problems requiring different capability.
Founded in 2013, we have concentrated on healthcare and life sciences rather than treating them as one vertical among several.
Our Voyant Health EHR and EMR work means patient matching against clinical records is handled by engineers with direct systems experience.
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls and documentation practice are established.
ISO 27001 certification means security controls are documented and auditable, supporting manufacturer and provider vendor assessment.
Medical device recalls management pricing depends on scope, whether you execute or receive recalls, distribution complexity, and clinical integration requirements. Patient identification integration is frequently the largest component for implantable device scenarios. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown after assessing traceability data quality. Cloud infrastructure and notification service costs are separate from engineering and itemized clearly.
An MVP covering recall database sync and inventory matching typically runs $40,000 to $80,000 for hospital-side deployment.
A full platform with scope analysis, notification, response tracking, and effectiveness documentation typically falls between $80,000 and $200,000.
Enterprise engagements covering manufacturer field actions, patient identification, and multi-facility matching start at $200,000.
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and traceability data quality assessment.
Clinical integration, distribution complexity, facility count, and traceability data condition are the largest variables, identified during discovery.
Post-launch regulatory changes, integration maintenance, and support are quoted separately as a retainer sized to portfolio or facility count.
If you are evaluating medical device recalls management software for field action execution, recall receipt, patient identification, or effectiveness tracking, the fastest next step is a discovery call with our team. We will assess traceability data quality and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
Quality and materials leaders evaluating medical device recalls management software usually ask how fast identification can be, whether the software determines recall classification, and what happens when traceability data is incomplete. The answers below reflect how we scope these projects.
As quickly as your traceability data allows. Where device identifiers were captured into implant records, matching takes minutes. Where capture was inconsistent, the system identifies what it can and exposes the gap, and manual chart review remains necessary for the remainder.
No. Classification reflecting hazard severity is determined by the manufacturer and FDA, not by software. The system supports execution, notification, tracking, and documentation once classification exists, and urgency handling follows the assigned class rather than computing it.
Then identification will be incomplete, and the system will show you exactly where. That visibility is genuinely useful, since it quantifies the gap and identifies which procedures or periods lack capture. It does not, however, retroactively create records that were never made.
An MVP covering database sync and inventory matching runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with patient identification start at $200,000. Clinical integration drives cost most.
Where appropriate and with provider involvement. Direct patient notification about a device recall is a clinical communication with real anxiety implications, so it should be led by the treating provider rather than issued automatically. The system supports coordination rather than replacing clinical judgment about how to communicate.
Yes, tracking acknowledgment and completion per recipient throughout execution. Effectiveness verification is examined during regulatory review of recall closure, and assembling that evidence afterward from email records is substantially harder than capturing it as the action proceeds.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.